FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4296137083> ?p ?o ?g. }

• W4296137083 endingPage "3708" @default.
• W4296137083 startingPage "3708" @default.
• W4296137083 abstract "Background: In patients with obesity and metabolic syndrome (MetS), lifestyle interventions combining diet, in particular, and physical exercise are recommended as the first line treatment. Previous studies have suggested that leucine or arginine supplementation may have beneficial effects on the body composition or insulin sensitivity and endothelial function, respectively. We thus conducted a randomized controlled study to evaluate the effects of a supervised adapted physical activity program associated or not with oral supplementation with leucine and arginine in MetS-complicated patients with obesity. Methods: Seventy-nine patients with obesity and MetS were randomized in four groups: patients receiving arginine and leucine supplementation (ALs group, n = 20), patients on a supervised adapted physical activity program (APA group, n = 20), patients combining ALs and APA (ALs+APA group, n = 20), and a control group (n = 19). After the baseline evaluation (m0), patients received ALs and/or followed the APA program for 6 months (m6). Body composition, MetS parameters, lipid and glucose metabolism markers, inflammatory markers, and a cardiopulmonary exercise test (CPET) were assessed at m0, m6, and after a 3-month wash-out period (m9). Results: After 6 months of intervention, we did not observe variable changes in body weight, body composition, lipid and glucose metabolism markers, inflammatory parameters, or quality of life scores between the four groups. However, during the CPET, the maximal power (Pmax and Ppeak), power, and O2 consumption at the ventilatory threshold (P(VT) and O2(VT)) were improved in the APA and ALs+APA groups (p < 0.05), as well as the forced vital capacity (FVC). Between m6 and m9, a gain in fat mass was only observed in patients in the APA and ALs+APA groups. Conclusion: In our randomized controlled trial, arginine and leucine supplementation failed to improve MetS in patients with obesity, as did the supervised adapted physical activity program and the combination of both. Only the cardiorespiratory parameters were improved by exercise training." @default.
• W4296137083 created "2022-09-17" @default.
• W4296137083 creator A5000577845 @default.
• W4296137083 creator A5013763671 @default.
• W4296137083 creator A5017285164 @default.
• W4296137083 creator A5018960460 @default.
• W4296137083 creator A5021534573 @default.
• W4296137083 creator A5028366470 @default.
• W4296137083 creator A5032617162 @default.
• W4296137083 creator A5034526107 @default.
• W4296137083 creator A5034575041 @default.
• W4296137083 creator A5034906246 @default.
• W4296137083 creator A5055530867 @default.
• W4296137083 creator A5062173171 @default.
• W4296137083 creator A5065286648 @default.
• W4296137083 creator A5073099637 @default.
• W4296137083 creator A5091345073 @default.
• W4296137083 date "2022-09-08" @default.
• W4296137083 modified "2023-09-25" @default.
• W4296137083 title "Evaluation of a Supervised Adapted Physical Activity Program Associated or Not with Oral Supplementation with Arginine and Leucine in Subjects with Obesity and Metabolic Syndrome: A Randomized Controlled Trial" @default.
• W4296137083 cites W1509983325 @default.
• W4296137083 cites W1837342020 @default.
• W4296137083 cites W1907574285 @default.
• W4296137083 cites W1915064308 @default.
• W4296137083 cites W1922904922 @default.
• W4296137083 cites W1945012169 @default.
• W4296137083 cites W1965356005 @default.
• W4296137083 cites W1966910239 @default.
• W4296137083 cites W1971400811 @default.
• W4296137083 cites W1980227770 @default.
• W4296137083 cites W1987144559 @default.
• W4296137083 cites W1988230873 @default.
• W4296137083 cites W2032173003 @default.
• W4296137083 cites W2037377025 @default.
• W4296137083 cites W2041903902 @default.
• W4296137083 cites W2052347111 @default.
• W4296137083 cites W2057424383 @default.
• W4296137083 cites W2072698145 @default.
• W4296137083 cites W2096688252 @default.
• W4296137083 cites W2096773810 @default.
• W4296137083 cites W2101927509 @default.
• W4296137083 cites W2102828736 @default.
• W4296137083 cites W2115771115 @default.
• W4296137083 cites W2123401906 @default.
• W4296137083 cites W2124299377 @default.
• W4296137083 cites W2128759000 @default.
• W4296137083 cites W2132381632 @default.
• W4296137083 cites W2137020601 @default.
• W4296137083 cites W2145386763 @default.
• W4296137083 cites W2157599980 @default.
• W4296137083 cites W2162557586 @default.
• W4296137083 cites W2167607978 @default.
• W4296137083 cites W2170030368 @default.
• W4296137083 cites W2176291653 @default.
• W4296137083 cites W2271830309 @default.
• W4296137083 cites W2299884836 @default.
• W4296137083 cites W2394667057 @default.
• W4296137083 cites W2413965274 @default.
• W4296137083 cites W2435431472 @default.
• W4296137083 cites W2550354041 @default.
• W4296137083 cites W2588472787 @default.
• W4296137083 cites W2783759334 @default.
• W4296137083 cites W2875160728 @default.
• W4296137083 cites W2982381894 @default.
• W4296137083 cites W3022878587 @default.
• W4296137083 cites W3035991258 @default.
• W4296137083 cites W3094167337 @default.
• W4296137083 cites W3108782569 @default.
• W4296137083 cites W3110648516 @default.
• W4296137083 cites W3163176696 @default.
• W4296137083 cites W3185251035 @default.
• W4296137083 cites W4292806894 @default.
• W4296137083 cites W95218808 @default.
• W4296137083 doi "https://doi.org/10.3390/nu14183708" @default.
• W4296137083 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36145083" @default.
• W4296137083 hasPublicationYear "2022" @default.
• W4296137083 type Work @default.
• W4296137083 citedByCount "1" @default.
• W4296137083 countsByYear W42961370832023 @default.
• W4296137083 crossrefType "journal-article" @default.
• W4296137083 hasAuthorship W4296137083A5000577845 @default.
• W4296137083 hasAuthorship W4296137083A5013763671 @default.
• W4296137083 hasAuthorship W4296137083A5017285164 @default.
• W4296137083 hasAuthorship W4296137083A5018960460 @default.
• W4296137083 hasAuthorship W4296137083A5021534573 @default.
• W4296137083 hasAuthorship W4296137083A5028366470 @default.
• W4296137083 hasAuthorship W4296137083A5032617162 @default.
• W4296137083 hasAuthorship W4296137083A5034526107 @default.
• W4296137083 hasAuthorship W4296137083A5034575041 @default.
• W4296137083 hasAuthorship W4296137083A5034906246 @default.
• W4296137083 hasAuthorship W4296137083A5055530867 @default.
• W4296137083 hasAuthorship W4296137083A5062173171 @default.
• W4296137083 hasAuthorship W4296137083A5065286648 @default.
• W4296137083 hasAuthorship W4296137083A5073099637 @default.
• W4296137083 hasAuthorship W4296137083A5091345073 @default.
• W4296137083 hasBestOaLocation W42961370831 @default.
• W4296137083 hasConcept C126322002 @default.
• W4296137083 hasConcept C134018914 @default.

• next